Project Grant HT94252310673
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$339K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $302,228 project grant to The Regents of the University of California, San Francisco to support research on "Establishing and Overcoming the Mechanisms of Liver Metastasis-Induced Systemic Tumor Immune Tolerance and Immunotherapy Resistance in Melanoma." The 3-year grant project, running from September 30, 2023 to September 29, 2026, will investigate the biological mechanisms by...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $959,882.00 to The Regents of the University of California, San Francisco (UCSF) to establish and overcome the mechanisms of liver metastasis-induced systemic tumor immune tolerance and immunotherapy resistance in melanoma. The 3-year research project aims to investigate fundamental biological processes and develop new therapeutic approaches to enhance the...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,292,000.00 to the University of California, San Francisco (UCSF) to conduct in vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer. The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical investigations. The 4-year research project will involve...
This federal Project Grant award of $1,008,313.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support melanoma research conducted by The Regents of the University of California, San Francisco (UCSF). The funding will enable UCSF's team of researchers to pursue advanced, innovative scientific investigations focused on transforming healthcare for military service members and the broader public. The 3-year research effort, spanning...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports melanoma research through a team science approach at the University of California, San Francisco (UCSF), with a performance period from September 1, 2024 to August 31, 2027. The grant will fund UCSF's cutting-edge research initiatives focused on transforming healthcare for military service members...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
The Regents of the University of California, San Francisco will receive $564,954 under a three-year Project Grant from the Department of the Army Medical Command to identify novel therapeutic strategies for metastatic uveal melanoma through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and...
This $1,211,127 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports a research project by the University of California, San Francisco (UCSF) to investigate the importance of immune responses to prostate tumor antigens primed by a combination of radiation and immunotherapy. The 4-year project aims to advance understanding of how to leverage the body's immune system to improve treatments for prostate cancer. As...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), has awarded a $947,746 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) to conduct research on "IDENTIFICATION OF THE LIVER MICROENVIRONMENT THAT DRIVES UVEAL MELANOMA METASTASIS AND IMMUNITY". The 3-year grant, beginning on September 1, 2024 and ending on August 31, 2027, will enable DFCI, a non-profit cancer research center in Boston, MA, to investigate the liver...